vs
AXCELIS TECHNOLOGIES INC（ACLS）与IONIS PHARMACEUTICALS INC（IONS）财务数据对比。点击上方公司名可切换其他公司
AXCELIS TECHNOLOGIES INC的季度营收约是IONIS PHARMACEUTICALS INC的1.2倍（$238.3M vs $203.3M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs -112.8%，领先127.2%），AXCELIS TECHNOLOGIES INC同比增速更快（-5.6% vs -10.3%），AXCELIS TECHNOLOGIES INC自由现金流更多（$-8.9M vs $-159.0M），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs -2.8%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
ACLS vs IONS — 直观对比
营收规模更大
ACLS
是对方的1.2倍
$203.3M
营收增速更快
ACLS
高出4.7%
-10.3%
净利率更高
ACLS
高出127.2%
-112.8%
自由现金流更多
ACLS
多$150.1M
$-159.0M
两年增速更快
IONS
近两年复合增速
-2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $203.3M |
| 净利润 | $34.3M | $-229.4M |
| 毛利率 | 47.0% | 96.1% |
| 营业利润率 | 15.2% | -105.5% |
| 净利率 | 14.4% | -112.8% |
| 营收同比 | -5.6% | -10.3% |
| 净利润同比 | -31.3% | -119.8% |
| 每股收益（稀释后） | $1.11 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSIONS
| Q4 25 | $238.3M | $203.3M | ||
| Q3 25 | $213.6M | $156.7M | ||
| Q2 25 | $194.5M | $452.0M | ||
| Q1 25 | $192.6M | $131.6M | ||
| Q4 24 | $252.4M | $226.6M | ||
| Q3 24 | $256.6M | $133.8M | ||
| Q2 24 | $256.5M | $225.3M | ||
| Q1 24 | $252.4M | $119.5M |
净利润ACLSIONS
| Q4 25 | $34.3M | $-229.4M | ||
| Q3 25 | $26.0M | $-128.6M | ||
| Q2 25 | $31.4M | $123.6M | ||
| Q1 25 | $28.6M | $-146.9M | ||
| Q4 24 | $50.0M | $-104.3M | ||
| Q3 24 | $48.6M | $-140.5M | ||
| Q2 24 | $50.9M | $-66.3M | ||
| Q1 24 | $51.6M | $-142.8M |
毛利率ACLSIONS
| Q4 25 | 47.0% | 96.1% | ||
| Q3 25 | 41.6% | 98.5% | ||
| Q2 25 | 44.9% | 99.1% | ||
| Q1 25 | 46.1% | 98.9% | ||
| Q4 24 | 46.0% | 98.3% | ||
| Q3 24 | 42.9% | 99.2% | ||
| Q2 24 | 43.8% | 98.2% | ||
| Q1 24 | 46.0% | 98.2% |
营业利润率ACLSIONS
| Q4 25 | 15.2% | -105.5% | ||
| Q3 25 | 11.7% | -102.2% | ||
| Q2 25 | 14.9% | 30.9% | ||
| Q1 25 | 15.1% | -111.6% | ||
| Q4 24 | 21.6% | -48.9% | ||
| Q3 24 | 18.3% | -111.1% | ||
| Q2 24 | 20.6% | -29.3% | ||
| Q1 24 | 22.4% | -125.1% |
净利率ACLSIONS
| Q4 25 | 14.4% | -112.8% | ||
| Q3 25 | 12.2% | -82.1% | ||
| Q2 25 | 16.1% | 27.3% | ||
| Q1 25 | 14.8% | -111.6% | ||
| Q4 24 | 19.8% | -46.1% | ||
| Q3 24 | 18.9% | -105.0% | ||
| Q2 24 | 19.8% | -29.4% | ||
| Q1 24 | 20.4% | -119.5% |
每股收益（稀释后）ACLSIONS
| Q4 25 | $1.11 | $-1.35 | ||
| Q3 25 | $0.83 | $-0.80 | ||
| Q2 25 | $0.98 | $0.70 | ||
| Q1 25 | $0.88 | $-0.93 | ||
| Q4 24 | $1.54 | $-0.66 | ||
| Q3 24 | $1.49 | $-0.95 | ||
| Q2 24 | $1.55 | $-0.45 | ||
| Q1 24 | $1.57 | $-0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $2.7B |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $1.0B | $489.1M |
| 总资产 | $1.4B | $3.5B |
| 负债/权益比越低杠杆越低 | — | 3.71× |
8季度趋势，按日历期对齐
现金及短期投资ACLSIONS
| Q4 25 | $374.3M | $2.7B | ||
| Q3 25 | $449.6M | $2.2B | ||
| Q2 25 | $549.8M | $2.3B | ||
| Q1 25 | $587.1M | $2.1B | ||
| Q4 24 | $571.3M | $2.3B | ||
| Q3 24 | $579.4M | $2.5B | ||
| Q2 24 | $548.3M | $2.1B | ||
| Q1 24 | $530.2M | $2.2B |
总债务ACLSIONS
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACLSIONS
| Q4 25 | $1.0B | $489.1M | ||
| Q3 25 | $1.0B | $618.0M | ||
| Q2 25 | $1.0B | $631.7M | ||
| Q1 25 | $1.0B | $475.7M | ||
| Q4 24 | $1.0B | $588.4M | ||
| Q3 24 | $975.6M | $662.5M | ||
| Q2 24 | $934.9M | $263.7M | ||
| Q1 24 | $901.7M | $296.5M |
总资产ACLSIONS
| Q4 25 | $1.4B | $3.5B | ||
| Q3 25 | $1.4B | $3.0B | ||
| Q2 25 | $1.3B | $3.0B | ||
| Q1 25 | $1.3B | $2.8B | ||
| Q4 24 | $1.3B | $3.0B | ||
| Q3 24 | $1.3B | $3.1B | ||
| Q2 24 | $1.3B | $2.7B | ||
| Q1 24 | $1.3B | $2.8B |
负债/权益比ACLSIONS
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $-159.0M |
| 自由现金流率自由现金流/营收 | -3.7% | -78.2% |
| 资本支出强度资本支出/营收 | 1.0% | 10.5% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | $107.0M | $-320.0M |
8季度趋势，按日历期对齐
经营现金流ACLSIONS
| Q4 25 | $-6.6M | $-137.7M | ||
| Q3 25 | $45.4M | $-131.4M | ||
| Q2 25 | $39.7M | $151.3M | ||
| Q1 25 | $39.8M | $-150.8M | ||
| Q4 24 | $12.8M | $-116.1M | ||
| Q3 24 | $45.7M | $-115.0M | ||
| Q2 24 | $40.1M | $-119.9M | ||
| Q1 24 | $42.2M | $-149.9M |
自由现金流ACLSIONS
| Q4 25 | $-8.9M | $-159.0M | ||
| Q3 25 | $43.3M | $-136.7M | ||
| Q2 25 | $37.7M | $139.0M | ||
| Q1 25 | $34.8M | $-163.4M | ||
| Q4 24 | $8.1M | $-141.6M | ||
| Q3 24 | $41.8M | $-124.0M | ||
| Q2 24 | $38.1M | $-126.1M | ||
| Q1 24 | $40.6M | $-154.4M |
自由现金流率ACLSIONS
| Q4 25 | -3.7% | -78.2% | ||
| Q3 25 | 20.3% | -87.2% | ||
| Q2 25 | 19.4% | 30.8% | ||
| Q1 25 | 18.1% | -124.1% | ||
| Q4 24 | 3.2% | -62.5% | ||
| Q3 24 | 16.3% | -92.7% | ||
| Q2 24 | 14.8% | -56.0% | ||
| Q1 24 | 16.1% | -129.2% |
资本支出强度ACLSIONS
| Q4 25 | 1.0% | 10.5% | ||
| Q3 25 | 0.9% | 3.4% | ||
| Q2 25 | 1.0% | 2.7% | ||
| Q1 25 | 2.6% | 9.6% | ||
| Q4 24 | 1.8% | 11.3% | ||
| Q3 24 | 1.5% | 6.8% | ||
| Q2 24 | 0.8% | 2.8% | ||
| Q1 24 | 0.6% | 3.8% |
现金转化率ACLSIONS
| Q4 25 | -0.19× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.27× | 1.22× | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
